Report Detail

Medical Devices & Consumables Global Pharma ADMET Testing Market Growth (Status and Outlook) 2022-2028

  • RnM4473955
  • |
  • 27 July, 2022
  • |
  • Global
  • |
  • 102 Pages
  • |
  • LPI(LP Information)
  • |
  • Medical Devices & Consumables

The global market for Pharma ADMET Testing is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Pharma ADMET Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Pharma ADMET Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Pharma ADMET Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Pharma ADMET Testing market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Pharma ADMET Testing players cover CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation and Merck KGaA, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Pharma ADMET Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Pharma ADMET Testing market, with both quantitative and qualitative data, to help readers understand how the Pharma ADMET Testing market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Pharma ADMET Testing market and forecasts the market size by Type (In Vivo ADMET Testing and In Vitro ADMET Testing,), by Application (Systemic Toxicity Testing, Hepatotoxicity Testing, Renal Toxicity Testing and Neurotoxicity Testing), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
In Vivo ADMET Testing
In Vitro ADMET Testing

Segmentation by application
Systemic Toxicity Testing
Hepatotoxicity Testing
Renal Toxicity Testing
Neurotoxicity Testing
Others

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
CMIC Holdings
Charles River Laboratories
WuXi AppTec
Promega Corporation
Merck KGaA
Agilient Technologies
Biovia (Dassault Systemes)
Cyprotex Limited
Bio-Rad Laboratories
IQVIA

Chapter Introduction
Chapter 1: Scope of Pharma ADMET Testing, Research Methodology, etc.
Chapter 2: Executive Summary, global Pharma ADMET Testing market size and CAGR, Pharma ADMET Testing market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Pharma ADMET Testing revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Pharma ADMET Testing revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Pharma ADMET Testing market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including CMIC Holdings, Charles River Laboratories, WuXi AppTec, Promega Corporation, Merck KGaA, Agilient Technologies, Biovia (Dassault Systemes), Cyprotex Limited and Bio-Rad Laboratories and etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Pharma ADMET Testing Market Size 2017-2028
    • 2.1.2 Pharma ADMET Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Pharma ADMET Testing Segment by Type
    • 2.2.1 In Vivo ADMET Testing
    • 2.2.2 In Vitro ADMET Testing
  • 2.3 Pharma ADMET Testing Market Size by Type
    • 2.3.1 Pharma ADMET Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Pharma ADMET Testing Market Size Market Share by Type (2017-2022)
  • 2.4 Pharma ADMET Testing Segment by Application
    • 2.4.1 Systemic Toxicity Testing
    • 2.4.2 Hepatotoxicity Testing
    • 2.4.3 Renal Toxicity Testing
    • 2.4.4 Neurotoxicity Testing
    • 2.4.5 Others
  • 2.5 Pharma ADMET Testing Market Size by Application
    • 2.5.1 Pharma ADMET Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Pharma ADMET Testing Market Size Market Share by Application (2017-2022)

3 Pharma ADMET Testing Market Size by Player

  • 3.1 Pharma ADMET Testing Market Size Market Share by Players
    • 3.1.1 Global Pharma ADMET Testing Revenue by Players (2020-2022)
    • 3.1.2 Global Pharma ADMET Testing Revenue Market Share by Players (2020-2022)
  • 3.2 Global Pharma ADMET Testing Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Pharma ADMET Testing by Regions

  • 4.1 Pharma ADMET Testing Market Size by Regions (2017-2022)
  • 4.2 Americas Pharma ADMET Testing Market Size Growth (2017-2022)
  • 4.3 APAC Pharma ADMET Testing Market Size Growth (2017-2022)
  • 4.4 Europe Pharma ADMET Testing Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Pharma ADMET Testing Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Pharma ADMET Testing Market Size by Country (2017-2022)
  • 5.2 Americas Pharma ADMET Testing Market Size by Type (2017-2022)
  • 5.3 Americas Pharma ADMET Testing Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Pharma ADMET Testing Market Size by Region (2017-2022)
  • 6.2 APAC Pharma ADMET Testing Market Size by Type (2017-2022)
  • 6.3 APAC Pharma ADMET Testing Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Pharma ADMET Testing by Country (2017-2022)
  • 7.2 Europe Pharma ADMET Testing Market Size by Type (2017-2022)
  • 7.3 Europe Pharma ADMET Testing Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Pharma ADMET Testing by Region (2017-2022)
  • 8.2 Middle East & Africa Pharma ADMET Testing Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Pharma ADMET Testing Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Pharma ADMET Testing Market Forecast

  • 10.1 Global Pharma ADMET Testing Forecast by Regions (2023-2028)
    • 10.1.1 Global Pharma ADMET Testing Forecast by Regions (2023-2028)
    • 10.1.2 Americas Pharma ADMET Testing Forecast
    • 10.1.3 APAC Pharma ADMET Testing Forecast
    • 10.1.4 Europe Pharma ADMET Testing Forecast
    • 10.1.5 Middle East & Africa Pharma ADMET Testing Forecast
  • 10.2 Americas Pharma ADMET Testing Forecast by Country (2023-2028)
    • 10.2.1 United States Pharma ADMET Testing Market Forecast
    • 10.2.2 Canada Pharma ADMET Testing Market Forecast
    • 10.2.3 Mexico Pharma ADMET Testing Market Forecast
    • 10.2.4 Brazil Pharma ADMET Testing Market Forecast
  • 10.3 APAC Pharma ADMET Testing Forecast by Region (2023-2028)
    • 10.3.1 China Pharma ADMET Testing Market Forecast
    • 10.3.2 Japan Pharma ADMET Testing Market Forecast
    • 10.3.3 Korea Pharma ADMET Testing Market Forecast
    • 10.3.4 Southeast Asia Pharma ADMET Testing Market Forecast
    • 10.3.5 India Pharma ADMET Testing Market Forecast
    • 10.3.6 Australia Pharma ADMET Testing Market Forecast
  • 10.4 Europe Pharma ADMET Testing Forecast by Country (2023-2028)
    • 10.4.1 Germany Pharma ADMET Testing Market Forecast
    • 10.4.2 France Pharma ADMET Testing Market Forecast
    • 10.4.3 UK Pharma ADMET Testing Market Forecast
    • 10.4.4 Italy Pharma ADMET Testing Market Forecast
    • 10.4.5 Russia Pharma ADMET Testing Market Forecast
  • 10.5 Middle East & Africa Pharma ADMET Testing Forecast by Region (2023-2028)
    • 10.5.1 Egypt Pharma ADMET Testing Market Forecast
    • 10.5.2 South Africa Pharma ADMET Testing Market Forecast
    • 10.5.3 Israel Pharma ADMET Testing Market Forecast
    • 10.5.4 Turkey Pharma ADMET Testing Market Forecast
    • 10.5.5 GCC Countries Pharma ADMET Testing Market Forecast
  • 10.6 Global Pharma ADMET Testing Forecast by Type (2023-2028)
  • 10.7 Global Pharma ADMET Testing Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 CMIC Holdings
    • 11.1.1 CMIC Holdings Company Information
    • 11.1.2 CMIC Holdings Pharma ADMET Testing Product Offered
    • 11.1.3 CMIC Holdings Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 CMIC Holdings Main Business Overview
    • 11.1.5 CMIC Holdings Latest Developments
  • 11.2 Charles River Laboratories
    • 11.2.1 Charles River Laboratories Company Information
    • 11.2.2 Charles River Laboratories Pharma ADMET Testing Product Offered
    • 11.2.3 Charles River Laboratories Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Charles River Laboratories Main Business Overview
    • 11.2.5 Charles River Laboratories Latest Developments
  • 11.3 WuXi AppTec
    • 11.3.1 WuXi AppTec Company Information
    • 11.3.2 WuXi AppTec Pharma ADMET Testing Product Offered
    • 11.3.3 WuXi AppTec Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 WuXi AppTec Main Business Overview
    • 11.3.5 WuXi AppTec Latest Developments
  • 11.4 Promega Corporation
    • 11.4.1 Promega Corporation Company Information
    • 11.4.2 Promega Corporation Pharma ADMET Testing Product Offered
    • 11.4.3 Promega Corporation Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Promega Corporation Main Business Overview
    • 11.4.5 Promega Corporation Latest Developments
  • 11.5 Merck KGaA
    • 11.5.1 Merck KGaA Company Information
    • 11.5.2 Merck KGaA Pharma ADMET Testing Product Offered
    • 11.5.3 Merck KGaA Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Merck KGaA Main Business Overview
    • 11.5.5 Merck KGaA Latest Developments
  • 11.6 Agilient Technologies
    • 11.6.1 Agilient Technologies Company Information
    • 11.6.2 Agilient Technologies Pharma ADMET Testing Product Offered
    • 11.6.3 Agilient Technologies Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Agilient Technologies Main Business Overview
    • 11.6.5 Agilient Technologies Latest Developments
  • 11.7 Biovia (Dassault Systemes)
    • 11.7.1 Biovia (Dassault Systemes) Company Information
    • 11.7.2 Biovia (Dassault Systemes) Pharma ADMET Testing Product Offered
    • 11.7.3 Biovia (Dassault Systemes) Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Biovia (Dassault Systemes) Main Business Overview
    • 11.7.5 Biovia (Dassault Systemes) Latest Developments
  • 11.8 Cyprotex Limited
    • 11.8.1 Cyprotex Limited Company Information
    • 11.8.2 Cyprotex Limited Pharma ADMET Testing Product Offered
    • 11.8.3 Cyprotex Limited Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Cyprotex Limited Main Business Overview
    • 11.8.5 Cyprotex Limited Latest Developments
  • 11.9 Bio-Rad Laboratories
    • 11.9.1 Bio-Rad Laboratories Company Information
    • 11.9.2 Bio-Rad Laboratories Pharma ADMET Testing Product Offered
    • 11.9.3 Bio-Rad Laboratories Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Bio-Rad Laboratories Main Business Overview
    • 11.9.5 Bio-Rad Laboratories Latest Developments
  • 11.10 IQVIA
    • 11.10.1 IQVIA Company Information
    • 11.10.2 IQVIA Pharma ADMET Testing Product Offered
    • 11.10.3 IQVIA Pharma ADMET Testing Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 IQVIA Main Business Overview
    • 11.10.5 IQVIA Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Pharma ADMET Testing. Industry analysis & Market Report on Pharma ADMET Testing is a syndicated market report, published as Global Pharma ADMET Testing Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Pharma ADMET Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
3,034.14
6,068.28
3,597.78
7,195.56
494,136.60
988,273.20
290,457.60
580,915.20
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report